Growth factors in angiogenesis: Current interest and therapeutic potential

Molecular Medicine Today

Volumn 3, Issue 1, 1997, Pages 14-23

  Colville Nash, P R ^a   Willoughby, D A ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ANGIOGENESIS; BLOOD VESSEL; CONTROL SYSTEM; DIABETES MELLITUS; DUODENUM ULCER; EMBRYO DEVELOPMENT; HUMAN; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; WOUND HEALING;

EID: 0031417899     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(96)10048-4     Document Type: Review

References (59)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? (G.H.A. Clowes memorial Award lecture) Cancer Res. 46 1986 467 473
2. Colville-Nash P.R. Scott D.L. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications Ann. Rheum. Dis. 51 1992 919 925
3. Ausprunk D.H. Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis Microvasc. Res. 14 1977 53 65
4. Abbot S.E. Kaul A. Stevens C.R. Blake D.R. Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression Arthritis Rheum. 35 1992 401 406
5. Kraling B.M. Jimenez S.A. Sorger T. Maul G.G. Isolation and characterization of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis Lab. Invest. 71 1994 745 754
6. Frater-Schroder M. Tumour necrosis factor α, a potent inhibitor of endothelial cell growth in vitro , is angiogenic in vivo Proc. Natl. Acad. Sci. U. S. A. 84 1987 5277 5281
7. Cockerill G.W. Gamble J.R. Vadas M.A. Angiogenesis: models and modulators Int. Rev. Cytol. 159 1995 113 160
8. Colville-Nash P.R. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation J. Pharmacol. Exp. Ther. 274 1995 1463 1472
9. Andrade S.P. Fan T.P. Lewis G.P. Quantitative in vivo studies on angiogenesis in a rat sponge model Br. J. Exp. Pathol. 68 1987 755 766
10. Klagsbrun M. D'Amore P.A. Regulators of angiogenesis Annu. Rev. Physiol. 53 1991 217 239
11. Risau W. Angiogenic growth factors Prog. Growth Factor Res. 2 1990 71 79
12. Colville-Nash P.R. Seed M.P. The current state of angiostatic therapy, with special reference to rheumatoid arthritis Curr. Opin. Invest. Drugs 2 1993 763 813
13. Dvorak H.F. Brown L.F. Detmar M. Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis Am. J. Pathol. 146 1995 1029 1039
14. Vlodavsky I. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumour metastasis and angiogenesis Cancer Metastasis Rev. 9 1990 203 226
15. Senger D.R. Commentary: molecular framework for angiogenesis. A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines Am. J. Pathol. 149 1996 1 7
16. Shweiki D. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors suggest a role in hormonally regulated angiogenesis J. Clin. Invest. 91 1993 2235 2243
17. Shalaby F. Failure in blood island formation and vasculogenesis in Flk-1-deficient mice Nature 376 1995 62 66
18. Asahara T. Local delivery of vascular endothelial growth factor accelerates re-endothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery Circulation 91 1995 2793 2801
19. Kuzuya M. Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque J. Cell Physiol. 164 1995 658 667
20. Kim K.J. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 362 1993 841 844
21. Appleton I. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue airpouch model of angiogenesis J. Pathol. 180 1996 90 94
22. Adamis A.P. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a non-human primate Arch. Ophthalmol. 114 1996 66 71
23. Pearlman J.D. Magnetic resonance mapping demonstrates benefits of VEGF induced myocardial angiogenesis Nat. Med. 1 1995 1085 1089
24. Takeshita S. A single ultra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischaemic hind limb model J. Clin. Invest. 93 1994 662 670
25. Ramakrishnan S. Olson T.A. Bautch V.L. Mohanraj D. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1 -positive endothelial cell proliferation in vitro and angiogenesis in vivo Cancer Res. 56 1996 1324 1330
26. v integrins Science 270 1995 1500 1502
27. Klagsbrun M. Soker S. VEGF/VPF: the angiogenesis factor found? Curr. Biol. 3 1993 699 702
28. Slavin I. Fibroblast growth factors: at the heart of angiogenesis Cell Biol. Int. 19 1995 431 444
29. Matsuzaki K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that blocks its biological activity: invalidity of the antibodies for tumour angiogenesis Proc. Natl. Acad. Sci. U. S. A. 86 1989 9911 9915
30. Unger E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model Am. J. Physiol. 266 1994 1588 1595
31. Fitzpatrick L.R. Acidic fibroblast growth factor accelerates the healing of the acetic-acid-induced gastric ulcers in rats Digestion 53 1992 17 27
32. Szabo S. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats Gastrenterology 106 1994 1106 1111
33. Stricter R.M. The role of CXC chemokines as regulators of angiogenesis Shock 4 1995 155 160
34. Koch A.E. Interleukin-8 as a macrophage derived mediator of angiogenesis Science 258 1992 1798 1801
35. Nickoloff B.J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis Am. J. Pathol. 144 1994 820 828
36. 165 using several concurrent mechanisms J. Biol. Chem. 270 1995 15059 15065
37. Strieter R.M. Interferon α-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis Biochem. Biophys. Res. Commun. 210 1995 51 57
38. Stricter R.M. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis J. Biol. Chem. 270 1995 27348 27357
39. Cao Y. gro-β, a C-X-C chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice J. Exp. Med. 182 1995 2069 2077
40. Voest E.E. Inhibition of angiogenesis in vivo by interleukin 12 J. Natl. Cancer Inst. 87 1995 581 586
41. Sgadari C. Angiolillo A.L. Tosato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10 Blood 87 1996 3877 3882
42. Folkman J. Clinical applications of research on angiogenesis New Engl. J. Med. 333 1995 1757 1763
43. Bornstein P. Thrombospondins: structure and regulation of expression FASEB J. 6 1992 3290 3299
44. Good D.J. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin Proc. Natl Acad. Sci. U. S. A. 87 1990 6624 6628
45. Zabrenetzky V. Harris C.C. Steeg P.S. Roberts D.D. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines Int. J. Cancer 59 1994 191 195
46. Weinstat-Saslow D.L. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis Cancer Res. 54 1994 6504 6511
47. 2+-binding extracellular protein associated with endothelial cell injury and proliferation J. Mol Cell Cardiol. 21 Suppl. 1 1989 13 22
48. Hasselaar P. Sage E.H. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells J. Cell Biochem. 49 1992 272 283
49. (Suppl.) Sage E.H. Vernon R.B. Regulation of angiogenesis by extracellular matrix: the growth and the glue J. Hypertens. 12 1994 S145 S152
50. Iruela-Arispe M.L. Expression of SPARC during development of the chick chorioallantoic membrane: evidence for regulated proteolysis in vivo Mol. Biol. Cell 6 1995 327 343
51. O'Reilly M.S. Angiostatin: a novel inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
52. Holmgren L. O'Reilly M.S. Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat. Med. 1 1995 149 153
53. O'Reilly M.S. Holmgren L. Chen C. Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice Nat. Med. 2 1996 689 692
54. Folkman J. Tumor angiogenesis: therapeutic implications New Engl. J. Med. 285 1971 1182 1186
55. Mousa S.A. Angiogenesis promoters and inhibitors: potential therapeutic implications Mol. Med. Today 2 1996 140 142
56. White C.W. Treatment of pulmonary hemangiomatosis with recombinant interferon α2a New Engl. J. Med. 320 1989 1197 1200
57. Kirkwood J.M. Interferon α2b adjuvant therapy of the high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684 J. Clin. Oncol. 14 1996 7 17
58. Kahn J. A Phase I/II study of recombinant platelet factor (rPF4) in patients with AIDS related Kaposi's sarcoma (KS) Proc. Am. Soc. Clin. Oncol. 12 1993 50
59. Hull M.A. Cullen D.J. Hudson C.N. Hawkey C.J. Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration Gut 37 1995 610 612